Results 241 to 250 of about 5,996,360 (285)
Some of the next articles are maybe not open access.
Current Opinion in Oncology, 1997
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
L, Balducci +3 more
+7 more sources
Prostate cancer accounted for over 41,000 deaths in the United States in 1996. Prostate-specific antigen (PSA) screening is capable of detecting prostate cancer and appears to detect cancers that are both clinically significant as well as organ-confined, and therefore potentially curable. The positive predictive value of PSA value has been increased by
L, Balducci +3 more
+7 more sources
Endocrinology and Metabolism Clinics of North America, 1994
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources
Prostate carcinoma is a growing concern in our aging society. While the disease often follows a indolent course, it is the second leading cause of cancer-related deaths in males. Prostate cancer screening is promising but remains unproven and controversial. The therapy of prostate cancer has changed little over the past 10 years.
W J, Ellis, P H, Lange
+7 more sources
The Lancet, 2008
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
In developed countries, prostate cancer is the second most frequently diagnosed cancer, and the third most common cause of death from cancer in men. Apart from age and ethnic origin, a positive family history is probably the strongest known risk factor.
Jan-Erik, Damber, Gunnar, Aus
openaire +4 more sources
Medical Clinics of North America, 1999
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
Prostate cancer is the second leading cause of cancer death in men. Recommendations for screening and treatment are usually made, especially in the popular press, without regard to patient age or medical health. This article focuses on the trade-off between the benefits and side effects of screening and treatment.
L E, Hahnfeld, T D, Moon
openaire +2 more sources
European Urology
BACKGROUND AND OBJECTIVE The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological ...
P. Cornford +30 more
semanticscholar +1 more source
BACKGROUND AND OBJECTIVE The European Association of Urology (EAU)-European Association of Nuclear Medicine (EANM)-European Society for Radiotherapy and Oncology (ESTRO)-European Society of Urogenital Radiology (ESUR)-International Society of Urological ...
P. Cornford +30 more
semanticscholar +1 more source
Oncology Times, 2005
Prostate cancer is biologically and clinically a heterogeneous disease and its imaging evaluation will need to be tailored to the specific phases of the disease in a patient-specific, risk-adapted manner. We first present a brief overview of the natural history of prostate cancer before discussing the role of various imaging tools, including ...
openaire +3 more sources
Prostate cancer is biologically and clinically a heterogeneous disease and its imaging evaluation will need to be tailored to the specific phases of the disease in a patient-specific, risk-adapted manner. We first present a brief overview of the natural history of prostate cancer before discussing the role of various imaging tools, including ...
openaire +3 more sources
Disease-a-Month, 1991
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources
Prostate cancer is the most common malignancy in men and the second leading cause of cancer deaths. Although the mortality rate for prostate cancer has remained unchanged for 50 years, new advances have changed classic concepts in the diagnosis and management of patients with this disease.
R A, Badalament, J R, Drago
openaire +2 more sources